Ausgabe 2/2017
Inhalt (22 Artikel)
Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis
Jingru Tian, Yien Luo, Juanjuan Xiang, Jingqun Tang
Prophylactic anticonvulsants in patients with primary glioblastoma
Arvin R. Wali, Robert C. Rennert, Sonya G. Wang, Clark C. Chen
Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma
Chenan Zhang, Adam J. de Smith, Ivan V. Smirnov, John K. Wiencke, Joseph L. Wiemels, John S. Witte, Kyle M. Walsh
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria
Michela Visani, Giorgia Acquaviva, Gianluca Marucci, Alexandro Paccapelo, Antonella Mura, Enrico Franceschi, Daniela Grifoni, Annalisa Pession, Giovanni Tallini, Alba A. Brandes, Dario de Biase
Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Puneet Gandhi, Richa Khare, Nitin Garg
SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway
Chuanjin Liu, Haibin Wu, Yanyan Li, Liang Shen, Renchun Yu, Hongwei Yin, Ting Sun, Chunming Sun, Youxin Zhou, Ziwei Du
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas
Olatz Etxaniz, Cristina Carrato, Itziar de Aguirre, Cristina Queralt, Ana Muñoz, José L. Ramirez, Rafael Rosell, Salvador Villà, Rocio Diaz, Ana Estival, Pilar Teixidor, Alberto Indacochea, Sara Ahjal, Laia Vilà, Carme Balañá
Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
Marc Zanello, Alexandre Roux, Renata Ursu, Sophie Peeters, Luc Bauchet, Georges Noel, Jacques Guyotat, Pierre-Jean Le Reste, Thierry Faillot, Fabien Litre, Nicolas Desse, Evelyne Emery, Antoine Petit, Johann Peltier, Jimmy Voirin, François Caire, Jean-Luc Barat, Jean-Rodolphe Vignes, Philippe Menei, Olivier Langlois, Edouard Dezamis, Antoine Carpentier, Phong Dam Hieu, Philippe Metellus, Johan Pallud
Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer
Nakamasa Hayashi, Koichi Mitsuya, Yoko Nakasu, Tateaki Naito, Fumiharu Ohka, Toshiaki Takahashi
A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma
Sophie E. M. Veldhuijzen van Zanten, Fatma E. El-Khouly, Marc H. A. Jansen, Dewi P. Bakker, Esther Sanchez Aliaga, Cornelis J. A. Haasbeek, Nicole I. Wolf, C. Michel Zwaan, W. Peter Vandertop, Dannis G. van Vuurden, Gertjan J. L. Kaspers
Radiomic features predict Ki-67 expression level and survival in lower grade gliomas
Yiming Li, Zenghui Qian, Kaibin Xu, Kai Wang, Xing Fan, Shaowu Li, Xing Liu, Yinyan Wang, Tao Jiang
Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma
Jay K. Nathan, Amanda L. Brezzell, Michelle M. Kim, Denise Leung, D. Andrew Wilkinson, Shawn L. Hervey-Jumper
Walking ability in patients with glioblastoma: prognostic value of the Berg Balance Scale and the 10 meter walk test
Monique Mesot Liljehult, Lise Buus, Jacob Liljehult, Birthe Krogh Rasmussen
Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide
Jian L. Campian, Anna F. Piotrowski, Xiaobu Ye, Frances T. Hakim, Jeremy Rose, Xiao-Yi Yan, Yao Lu, Ronald Gress, Stuart A. Grossman
Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma
Fu Zhao, Chunde Li, Qiangyi Zhou, Peiran Qu, Bo Wang, Xin Wang, Shun Zhang, Xingchao Wang, Chi Zhao, Jing Zhang, Lin Luo, Lin Ai, Lei Xu, Pinan Liu
Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study
Barbara Wegenschimmel, Ulrike Leiss, Michaela Veigl, Verena Rosenmayr, Anton Formann, Irene Slavc, Thomas Pletschko
Pseudoprogression in pediatric low-grade glioma after irradiation
Derek S. Tsang, Erin S. Murphy, John T. Lucas Jr., Pagona Lagiou, Sahaja Acharya, Thomas E. Merchant
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis
Anne Fogli, Marie-Véronique Demattei, Laetitia Corset, Catherine Vaurs-Barrière, Emmanuel Chautard, Julian Biau, Jean-Louis Kémény, Catherine Godfraind, Bruno Pereira, Toufik Khalil, Nathalie Grandin, Philippe Arnaud, Michel Charbonneau, Pierre Verrelle
Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival
Christian Henker, Thomas Kriesen, Änne Glass, Björn Schneider, Jürgen Piek
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram
Diandra N. Ayala-Peacock, Albert Attia, Steve E. Braunstein, Manmeet S. Ahluwalia, Jaroslaw Hepel, Caroline Chung, Joseph Contessa, Emory McTyre, Ann M. Peiffer, John T. Lucas Jr, Scott Isom, Nicholas M. Pajewski, Rupesh Kotecha, Mark J. Stavas, Brandi R. Page, Lawrence Kleinberg, Colette Shen, Robert B. Taylor, Nasarachi E. Onyeuku, Andrew T. Hyde, Daniel Gorovets, Samuel T. Chao, Christopher Corso, Jimmy Ruiz, Kounosuke Watabe, Stephen B. Tatter, Gelareh Zadeh, Veronica L. S. Chiang, John B. Fiveash, Michael D. Chan
High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases
Mengxi Ge, Yingjie Zhuang, Xinli Zhou, Ruofan Huang, Xiaohua Liang, Qiong Zhan
Extraneuraxial metastases in medulloblastoma: is histology and molecular biology important?
Tejpal Gupta, Archya Dasgupta, Sridhar Epari, Neelam Shirsat, Girish Chinnaswamy, Rakesh Jalali